Given the growing reports of antigen‐escape relapse in patients treated with CD19 CAR T cells, our next experiment was the functional characterization of BAFF‐R CAR T cells against CD19‐KO CLL. The gene discussed is CD19; the disease is B-cell chronic lymphocytic leukemia.